| Year |
Citation |
Score |
| 2024 |
Brody EM, Seo Y, Suh E, Amari N, Hartstone WG, Skrinak RT, Zhang H, Diaz-Ortiz ME, Weintraub D, Tropea TF, Van Deerlin VM, Chen-Plotkin AS. GPNMB Biomarker Levels in GBA1 Carriers with Lewy Body Disorders. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 38610104 DOI: 10.1002/mds.29773 |
0.61 |
|
| 2023 |
Diaz-Ortiz ME, Jain N, Gallagher MD, Posavi M, Unger TL, Chen-Plotkin AS. Testing for Allele-specific Expression from Human Brain Samples. Bio-Protocol. 13: e4832. PMID 37817908 DOI: 10.21769/BioProtoc.4832 |
0.774 |
|
| 2022 |
Diaz-Ortiz ME, Seo Y, Posavi M, Carceles Cordon M, Clark E, Jain N, Charan R, Gallagher MD, Unger TL, Amari N, Skrinak RT, Davila-Rivera R, Brody EM, Han N, Zack R, et al. GPNMB confers risk for Parkinson's disease through interaction with α-synuclein. Science (New York, N.Y.). 377: eabk0637. PMID 35981040 DOI: 10.1126/science.abk0637 |
0.33 |
|
| 2022 |
Li R, Tropea TF, Baratta LR, Zuroff L, Diaz-Ortiz ME, Zhang B, Shinoda K, Rezk A, Alcalay RN, Chen-Plotkin A, Bar-Or A. Abnormal B-Cell and Tfh-Cell Profiles in Patients With Parkinson Disease: A Cross-sectional Study. Neurology(R) Neuroimmunology & Neuroinflammation. 9. PMID 34955458 DOI: 10.1212/NXI.0000000000001125 |
0.75 |
|
| 2020 |
Diaz-Ortiz ME, Chen-Plotkin AS. Omics in Neurodegenerative Disease: Hope or Hype? Trends in Genetics : Tig. 36: 152-159. PMID 31932096 DOI: 10.1016/j.tig.2019.12.002 |
0.704 |
|
| 2019 |
Posavi M, Diaz-Ortiz M, Liu B, Swanson CR, Skrinak RT, Hernandez-Con P, Amado DA, Fullard M, Rick J, Siderowf A, Weintraub D, McCluskey L, Trojanowski JQ, Dewey RB, Huang X, et al. Characterization of Parkinson's disease using blood-based biomarkers: A multicohort proteomic analysis. Plos Medicine. 16: e1002931. PMID 31603904 DOI: 10.1371/Journal.Pmed.1002931 |
0.732 |
|
| Show low-probability matches. |